VOR Vor Biopharma Inc. - Common Stock
VOR Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
VOR Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
VOR Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 5 38,5%
- Achat 6 46,2%
- Conserver 2 15,4%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
8 analystes · 2026-08-17Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-5.11 | $-0.79 | -4.3% |
| 31 décembre 2025 | $25.84 | $-1.69 | 27.5% |
| 30 septembre 2025 | $-3.33 | $-3.28 | -0.05% |
| 30 juin 2025 | $-43.80 | $-8.86 | -34.9% |
| 31 mars 2025 | $-5.20 | $-4.62 | -0.58% |
| 31 décembre 2024 | $-8.80 | $-5.77 | -3.0% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| ODTX | — | — | — | — | — | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $322M | $93M | $94M | $65M | $48M | $32M | |
| SG&A Expense | $50M | $28M | $32M | $29M | $21M | $12M | |
| Operating Expenses | $372M | $121M | $126M | $93M | $69M | $43M | |
| Operating Income | $-372M | $-121M | $-126M | $-93M | $-69M | $-43M | |
| Interest Income | $6M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Other Non-op | $-324M | $4M | $8M | $1M | $119.0K | $29.0K | |
| Net Income | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| EPS (Basic) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| EPS (Diluted) | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 | · | |
| Shares (Basic) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| Shares (Diluted) | 9,871,866 | 3,435,533 | 67,191,973 | 39,551,420 | 33,433,214 | · | |
| EBITDA | $-372M | $-121M | $-126M | $-93M | $-69M | · |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $396M | $82M | $31M | $58M | $120M | $49M | |
| Short-term Investments | $59M | $10M | $106M | $173M | $88M | $0 | |
| Prepaid Expense | $1M | $4M | $3M | $4M | $5M | $467.0K | |
| Other Current Assets | $2M | $380.0K | $475.0K | $2M | $2M | $100.0K | |
| Current Assets | $458M | $97M | $141M | $237M | $214M | $49M | |
| PP&E (Net) | $533.0K | $7M | $10M | $13M | $7M | $5M | |
| PP&E (Gross) | $558.0K | $18M | $18M | $17M | $9M | $5M | |
| Accum. Depreciation | $25.0K | $11M | $8M | $5M | $2M | $726.0K | |
| Other Non-current Assets | $2M | $2M | $5M | $3M | $3M | $3M | |
| Total Assets | $464M | $143M | $198M | $299M | $243M | $76M | |
| Accounts Payable | $5M | $2M | $815.0K | $2M | $2M | $2M | |
| Accrued Liabilities | $20M | $13M | $11M | $8M | $6M | $6M | |
| Current Liabilities | $25M | $19M | $16M | $13M | $10M | $10M | |
| Capital Leases | $3M | $28M | $32M | $36M | $16M | $17M | |
| Total Liabilities | $628M | $46M | $47M | $49M | $26M | $28M | |
| Common Stock | $18.0K | $13.0K | $7.0K | $7.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.15B | $-457M | $-340M | $-222M | $-130M | $-61M | |
| AOCI | $41.0K | $22.0K | $-77.0K | $-770.0K | · | · | |
| Stockholders' Equity | $-164M | $97M | $151M | $251M | $216M | $-59M | |
| Liabilities + Equity | $464M | $143M | $198M | $299M | $243M | $76M | |
| Shares Outstanding | 38,720,196 | 6,238,799 | 3,395,072 | 65,996,138 | 37,174,741 | 505,074 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $10M | $13M | $11M | $4M | $1M | |
| Restructuring | $30M | · | · | · | · | · | |
| Operating Cash Flow | $-143M | $-100M | $-100M | $-85M | $-69M | $-36M | |
| CapEx | $941.0K | $229.0K | $1M | $8M | $4M | $4M | |
| Investing Cash Flow | $-49M | $97M | $71M | $-94M | $-92M | $-4M | |
| Stock Issued | $70M | $275.0K | $5M | $4M | · | · | |
| Net Stock Activity | $70M | $275.0K | $5M | $4M | · | · | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $504M | $53M | $3M | $117M | $233M | $83M | |
| Net Change in Cash | $312M | $51M | $-26M | $-62M | $72M | $42M | |
| Free Cash Flow | $-144M | $-100M | $-101M | $-94M | $-73M | · |
Rentabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -229.3% | -68.6% | -47.4% | -34.0% | -43.3% | · | |
| ROE | 83.4% | -137.8% | -72.4% | -45.0% | -30.7% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 | · | |
| Quick Ratio | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 | · |
Valorisation (TTM) 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-696M | $-117M | $-118M | $-92M | $-69M | $-43M | |
| Market Cap | $506M | $2.77B | $3.06B | $8.78B | $8.64B | · | |
| P/E | -0.2 | -0.7 | -25.7 | -57.1 | -110.7 | · | |
| P/B | -3.1 | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Tangible Book | · | 28.7 | 20.3 | 35.0 | 39.9 | · | |
| P / Cash Flow | -3.5 | -27.8 | -30.5 | -103.1 | -124.9 | · | |
| P / FCF | -3.5 | -27.7 | -30.1 | -93.8 | -118.3 | · | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Earnings Yield | -539.0% | -153.3% | -3.9% | -1.8% | -0.90% | · | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $18M | $19M | $14M | $261M | $27M | $25M | $22M | $22M | $24M | $21M | $28M | $24M | $22M | $17M | $17M | |
| SG&A Expense | $22M | $18M | $17M | $14M | $13M | $7M | $6M | $7M | $7M | $8M | $7M | $8M | $8M | $9M | $8M | $7M | |
| Operating Expenses | $48M | $35M | $36M | $28M | $274M | $33M | $31M | $29M | $29M | $32M | $28M | $35M | $32M | $30M | $25M | $24M | |
| Operating Income | $-48M | $-35M | $-36M | $-28M | $-274M | $-33M | $-31M | $-29M | $-29M | $-32M | $-28M | $-35M | $-32M | $-30M | $-25M | $-24M | |
| Interest Income | $4M | $4M | $3M | $2M | $537.0K | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Other Non-op | $-15M | $-184M | $1.76B | $-785M | $-1.30B | $805.0K | $599.0K | $954.0K | $1M | $2M | $2M | $2M | $2M | $2M | $815.0K | $313.0K | |
| Net Income | $-63M | $-220M | $1.72B | $-813M | $-1.57B | $-32M | $-31M | $-28M | $-28M | $-31M | $-26M | $-33M | $-30M | $-28M | $-24M | $-24M | |
| EPS (Basic) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| EPS (Diluted) | $-1.16 | $-5.11 | $63.95 | $-121.63 | $-251.24 | $-5.21 | $-25.12 | $-8.05 | $-0.41 | $-0.45 | $-0.38 | $-0.49 | $-0.45 | $-0.43 | $-0.51 | $-0.63 | |
| Shares (Basic) | 54,304,456 | 43,011,544 | -246,905,522 | 6,681,794 | 6,263,572 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | |
| Shares (Diluted) | 54,304,456 | 43,011,544 | -246,905,522 | 6,681,794 | 6,263,572 | 6,241,207 | -136,318,102 | 3,423,499 | 68,299,170 | 68,030,966 | -133,714,593 | 67,607,713 | 67,033,150 | 66,265,703 | -73,188,103 | 38,009,022 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-274M | $-33M | · | $-29M | $-29M | · | · | $-35M | $-32M | $-30M | · | $-24M |
Bilan 21
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $108M | $170M | $396M | $160M | $191M | $50M | $82M | $53M | $76M | $45M | $31M | $45M | $32M | $42M | $58M | $61M | |
| Short-term Investments | $358M | $322M | $59M | $10M | $10M | $10M | $10M | $10M | $10M | $63M | $106M | $115M | $155M | $168M | $173M | $75M | |
| Prepaid Expense | $6M | $6M | $1M | $747.0K | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $4M | $5M | |
| Other Current Assets | $3M | $3M | $2M | $1M | $449.0K | $297.0K | $380.0K | $285.0K | $272.0K | $507.0K | $475.0K | $667.0K | $539.0K | $459.0K | $2M | $2M | |
| Current Assets | $475M | $501M | $458M | $172M | $205M | $65M | $97M | $67M | $90M | $112M | $141M | $164M | $191M | $217M | $237M | $143M | |
| PP&E (Net) | $648.0K | $565.0K | $533.0K | $271.0K | $0 | $6M | $7M | $7M | $8M | $9M | $10M | $11M | $11M | $12M | $13M | $13M | |
| PP&E (Gross) | $738.0K | $618.0K | $558.0K | $272.0K | $0 | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $17M | |
| Accum. Depreciation | $90.0K | $53.0K | $25.0K | $1.0K | $0 | $12M | $11M | $11M | $10M | $9M | $8M | $7M | $6M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $269.0K | $420.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Total Assets | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Accounts Payable | $4M | $1M | $5M | $885.0K | $669.0K | $4M | $2M | $1M | $2M | $2M | $815.0K | $1M | $2M | $3M | $2M | $824.0K | |
| Accrued Liabilities | $20M | $15M | $20M | $18M | $58M | $9M | $13M | $9M | $8M | $7M | $11M | $10M | $7M | $5M | $8M | $6M | |
| Current Liabilities | $25M | $16M | $25M | $19M | $59M | $17M | $19M | $14M | $14M | $13M | $16M | $15M | $13M | $13M | $13M | $11M | |
| Capital Leases | $3M | $3M | $3M | $3M | $0 | $27M | $28M | $29M | $30M | $31M | $32M | $33M | $34M | $35M | $36M | $37M | |
| Total Liabilities | $681M | $657M | $628M | $2.40B | $1.71B | $43M | $46M | $43M | $44M | $44M | $47M | $48M | $47M | $47M | $49M | $48M | |
| Common Stock | $19.0K | $19.0K | $18.0K | $15.0K | $13.0K | $13.0K | $13.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | |
| Retained Earnings | $-1.44B | $-1.37B | $-1.15B | $-2.88B | $-2.06B | $-489M | $-457M | $-426M | $-399M | $-371M | $-340M | $-314M | $-281M | $-251M | $-222M | $-198M | |
| AOCI | $-922.0K | $-706.0K | $41.0K | $12.0K | $14.0K | $23.0K | $22.0K | $68.0K | $-70.0K | $-87.0K | $-77.0K | $-280.0K | $-436.0K | $-174.0K | $-770.0K | $-1M | |
| Stockholders' Equity | $-200M | $-150M | $-164M | $-2.23B | $-1.51B | $66M | $97M | $73M | $98M | $123M | $151M | $175M | $204M | $230M | $251M | $159M | |
| Liabilities + Equity | $481M | $507M | $464M | $176M | $205M | $109M | $143M | $116M | $142M | $167M | $198M | $223M | $251M | $278M | $299M | $206M | |
| Shares Outstanding | 54,455,751 | 54,185,582 | 38,720,196 | 9,026,922 | 125,645,952 | 124,851,547 | 6,238,799 | 68,663,065 | 68,357,884 | 68,215,771 | 67,891,311 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | |
| Restructuring | · | · | $0 | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-38M | $-23M | $-54M | $-35M | $-31M | $-24M | $-23M | $-22M | $-30M | $-24M | $-28M | $-24M | $-24M | $-18M | $-19M | |
| CapEx | $120.0K | $48.0K | $314.0K | $244.0K | $152.0K | $231.0K | $72.0K | $34.0K | $9.0K | $114.0K | $111.0K | $465.0K | $399.0K | $94.0K | $321.0K | $298.0K | |
| Investing Cash Flow | $-37M | $-263M | $-49M | $-244.0K | $646.0K | $-230.0K | $-72.0K | $-34.0K | $53M | $44M | $10M | $41M | $14M | $6M | $-97M | $13M | |
| Stock Issued | · | · | $50M | $20M | $0 | $0 | $-22.0K | $111.0K | $-92.0K | $278.0K | $-15.0K | $392.0K | $579.0K | $4M | $106.0K | $4M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-106.0K | $75M | $308M | $22M | $175M | $-606.0K | $53M | $41.0K | $-31.0K | $96.0K | $25.0K | $176.0K | $218.0K | $3M | $112M | $4M | |
| Net Change in Cash | $-62M | $-227M | $236M | $-32M | $141M | $-32M | $29M | $-23M | $31M | $14M | $-14M | $13M | $-10M | $-15M | $-3M | $-2M | |
| Free Cash Flow | · | $-38M | · | · | · | $-31M | · | · | · | · | · | · | · | $-24M | · | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.3% | -71.3% | · | -556.2% | -907.1% | -23.5% | · | -16.3% | -14.2% | · | · | -15.5% | -12.6% | -11.1% | · | -10.2% | |
| ROE | 7.4% | 520.6% | · | 75.5% | 223.6% | -34.4% | · | -22.2% | -18.4% | · | · | -19.9% | -15.8% | -13.4% | · | -12.2% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.1 | 31.1 | · | 9.2 | 3.5 | 3.9 | · | 4.7 | 6.5 | · | · | 10.7 | 15.1 | 17.2 | · | 12.9 | |
| Quick Ratio | 18.8 | 30.6 | · | 9.0 | 3.4 | 3.6 | · | 4.4 | 6.2 | · | · | 10.4 | 14.7 | 16.7 | · | 12.3 |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-2.67B | $-2.64B | · | $-2.45B | $-1.66B | $-119M | · | $-119M | $-122M | $-122M | · | $-115M | $-104M | $-97M | · | $-87M | |
| Market Cap | $1.00B | $967M | · | $440M | $4.07B | $1.79B | · | $961M | $1.37B | · | · | $2.87B | $4.17B | $7.20B | · | $3.06B | |
| P/E | -0.0 | -0.1 | · | -0.3 | -1.5 | -1.6 | · | -1.5 | -11.1 | -26.0 | · | -21.2 | -29.6 | -47.8 | · | -34.3 | |
| P/B | -5.0 | -6.4 | · | -0.2 | -2.7 | 27.1 | · | 13.2 | 13.9 | · | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Tangible Book | · | · | · | · | · | 27.1 | · | 13.2 | 13.9 | 26.3 | · | 16.4 | 20.4 | 31.3 | · | 19.3 | |
| P / Cash Flow | · | -25.3 | · | · | · | -57.7 | · | · | · | · | · | · | · | -296.8 | · | · | |
| P / FCF | · | -25.2 | · | · | · | -57.3 | · | · | · | · | · | · | · | -295.6 | · | · | |
| Earnings Yield | -2059.4% | -810.0% | · | -292.5% | -65.7% | -63.9% | · | -67.1% | -9.0% | -3.8% | · | -4.7% | -3.4% | -2.1% | · | -2.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-696M | $-117M | $-118M | $-92M | $-69M |
| BPA dilué | $-70.50 | $-34.03 | $-1.75 | $-2.33 | $-2.10 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 18.2 | 5.2 | 9.0 | 18.1 | 21.1 |
| Ratio de liquidité réduite | 18.1 | 4.9 | 8.8 | 17.6 | 20.4 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-144M | $-100M | $-101M | $-94M | $-73M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 103 déclarants · $806.9M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 42 (+8 vs T. préc.) | 17 (+7 vs T. préc.) | 31 (+6 vs T. préc.) | 20 (+9 vs T. préc.) | +5.6M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $104 441 366 | 5 673 078 | 12,94% | Actions |
| FMR LLC | $87 405 893 | 4 747 740 | 10,83% | Actions |
| FCPM III SERVICES B.V. | $75 800 487 | 4 117 354 | 9,39% | Actions |
| Venrock Adviser, LLC | $55 998 047 | 3 041 719 | 6,94% | Actions |
| STATE STREET CORP | $48 166 746 | 2 616 336 | 5,97% | Actions |
| Frazier Life Sciences Management, L.P. | $46 833 917 | 2 543 939 | 5,80% | Actions |
| RA CAPITAL MANAGEMENT, L.P. | $44 222 569 | 2 402 095 | 5,48% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $38 372 478 | 2 084 328 | 4,76% | Actions |
| Caligan Partners LP | $35 440 465 | 1 925 066 | 4,39% | Actions |
| Paradigm Biocapital Advisors LP | $32 217 500 | 1 750 000 | 3,99% | Actions |
| GREAT POINT PARTNERS LLC | $31 297 000 | 1 700 000 | 3,88% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $16 677 425 | 905 690 | 2,07% | Actions |
| NEXTBio Capital Management LP | $16 369 509 | 889 164 | 2,03% | Actions |
| Nantahala Capital Management, LLC | $15 556 450 | 845 000 | 1,93% | Actions |
| ADAR1 Capital Management, LLC | $12 530 325 | 680 626 | 1,55% | Actions |
| Logos Global Management LP | $11 966 500 | 650 000 | 1,48% | Actions |
| Rosalind Advisors, Inc. | $11 940 726 | 648 600 | 1,48% | Actions |
| NAN FUNG TRINITY (HK) LTD | $11 902 986 | 646 550 | 1,48% | Actions |
| BRAIDWELL LP | $10 550 845 | 573 104 | 1,31% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $10 285 704 | 558 702 | 1,27% | Actions |
| UBS Group AG | $8 937 300 | 485 459 | 1,11% | Actions |
| MILLENNIUM MANAGEMENT LLC | $7 880 713 | 428 067 | 0,98% | Actions |
| SPHERA FUNDS MANAGEMENT LTD. | $7 666 237 | 416 417 | 0,95% | Actions |
| Woodline Partners LP | $6 990 700 | 379 723 | 0,87% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6 266 101 | 340 364 | 0,78% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $5 535 961 | 300 704 | 0,69% | Actions |
| Clearline Capital LP | $5 251 931 | 285 276 | 0,65% | Actions |
| GOLDMAN SACHS GROUP INC | $4 182 623 | 227 193 | 0,52% | Actions |
| Eversept Partners, LP | $2 755 627 | 149 681 | 0,34% | Actions |
| BANK OF AMERICA CORP /DE/ | $2 384 942 | 129 546 | 0,30% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 234 937 | 121 398 | 0,28% | Actions |
| MARSHALL WACE, LLP | $1 760 788 | 95 643 | 0,22% | Actions |
| AXIOM INVESTORS LLC /DE | $1 695 653 | 92 105 | 0,21% | Actions |
| XTX Topco Ltd | $1 521 494 | 82 645 | 0,19% | Actions |
| CITADEL ADVISORS LLC | $1 328 668 | 72 171 | 0,16% | Actions |
| VANGUARD GROUP INC | $1 227 401 | 93 838 | 0,15% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 189 286 | 64 600 | 0,15% | Option de vente |
| CITIGROUP INC | $1 118 868 | 60 775 | 0,14% | Actions |
| BlackRock, Inc. | $1 082 103 | 58 778 | 0,13% | Actions |
| RHUMBLINE ADVISERS | $1 059 081 | 57 528 | 0,13% | Actions |
| ALPS ADVISORS INC | $1 012 513 | 54 998 | 0,13% | Actions |
| JOHNSON & JOHNSON | $989 206 | 53 732 | 0,12% | Actions |
| Rafferty Asset Management, LLC | $898 739 | 48 818 | 0,11% | Actions |
| Walleye Capital LLC | $858 127 | 46 612 | 0,11% | Actions |
| ALLIANCEBERNSTEIN L.P. | $685 036 | 37 210 | 0,08% | Actions |
| TWO SIGMA INVESTMENTS, LP | $681 391 | 37 012 | 0,08% | Actions |
| Engineers Gate Manager LP | $680 268 | 36 951 | 0,08% | Actions |
| WELLS FARGO & COMPANY/MN | $667 786 | 36 273 | 0,08% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $607 733 | 33 011 | 0,08% | Actions |
| Jefferies Financial Group Inc. | $601 326 | 32 663 | 0,07% | Actions |
| Bank of New York Mellon Corp | $502 133 | 27 275 | 0,06% | Actions |
| D. E. Shaw & Co., Inc. | $476 819 | 25 900 | 0,06% | Actions |
| Sarissa Capital Management LP | $467 596 | 25 399 | 0,06% | Actions |
| PROFUND ADVISORS LLC | $452 720 | 24 591 | 0,06% | Actions |
| MetLife Investment Management, LLC | $449 977 | 24 442 | 0,06% | Actions |
| Squarepoint Ops LLC | $427 683 | 23 231 | 0,05% | Actions |
| Virtus Investment Advisers, LLC | $419 472 | 22 785 | 0,05% | Actions |
| TUDOR INVESTMENT CORP ET AL | $361 204 | 19 620 | 0,04% | Actions |
| Scientech Research LLC | $346 623 | 18 828 | 0,04% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $344 451 | 18 710 | 0,04% | Actions |
| MORGAN STANLEY | $331 030 | 17 981 | 0,04% | Actions |
| Vanguard Global Advisers, LLC | $330 404 | 17 947 | 0,04% | Actions |
| Y-Intercept (Hong Kong) Ltd | $317 352 | 17 238 | 0,04% | Actions |
| JPMORGAN CHASE & CO | $314 656 | 16 917 | 0,04% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $302 918 | 16 454 | 0,04% | Actions |
| Invesco Ltd. | $299 568 | 16 272 | 0,04% | Actions |
| FOX RUN MANAGEMENT, L.L.C. | $281 691 | 15 301 | 0,03% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $263 263 | 14 300 | 0,03% | Actions |
| Shay Capital LLC | $252 125 | 13 695 | 0,03% | Actions |
| Police & Firemen's Retirement System of New Jersey | $221 564 | 12 035 | 0,03% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $198 699 | 10 793 | 0,02% | Actions |
| EntryPoint Capital, LLC | $198 552 | 10 785 | 0,02% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $197 134 | 10 708 | 0,02% | Actions |
| BARCLAYS PLC | $173 717 | 9 436 | 0,02% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $167 531 | 9 100 | 0,02% | Actions |
| Nuveen, LLC | $164 309 | 8 925 | 0,02% | Actions |
| SEI INVESTMENTS CO | $160 500 | 8 714 | 0,02% | Actions |
| China Universal Asset Management Co., Ltd. | $158 768 | 8 624 | 0,02% | Actions |
| NORTHERN TRUST CORP | $117 990 | 6 409 | 0,01% | Actions |
| Legal & General Group Plc | $72 940 | 3 962 | 0,01% | Actions |
| Ameritas Investment Partners, Inc. | $68 172 | 3 703 | 0,01% | Actions |
| Russell Investments Group, Ltd. | $59 942 | 3 256 | 0,01% | Actions |
| GROUP ONE TRADING LLC | $54 549 | 2 963 | 0,01% | Actions |
| Mirae Asset Global Investments Co., Ltd. | $44 607 | 2 423 | 0,01% | Actions |
| Global Retirement Partners, LLC | $38 458 | 2 089 | 0,00% | Actions |
| Pinnacle Wealth Planning Services, Inc. | $36 360 | 1 975 | 0,00% | Actions |
| Tower Research Capital LLC (TRC) | $32 052 | 1 741 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $23 000 | 1 259 | 0,00% | Actions |
| GF FUND MANAGEMENT CO. LTD. | $19 736 | 1 072 | 0,00% | Actions |
| DEUTSCHE BANK AG\ | $9 886 | 537 | 0,00% | Actions |
| Sterling Capital Management LLC | $6 536 | 355 | 0,00% | Actions |
| Jump Financial, LLC | $5 320 | 289 | 0,00% | Actions |
| PNC Financial Services Group, Inc. | $5 302 | 288 | 0,00% | Actions |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $3 314 | 180 | 0,00% | Actions |
| SIGNATUREFD, LLC | $2 706 | 147 | 0,00% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $1 252 | 68 | 0,00% | Actions |
| PRICE T ROWE ASSOCIATES INC /MD/ | $770 | 41 815 | 0,00% | Actions |
| WPG Advisers, LLC | $405 | 22 | 0,00% | Actions |
| Allworth Financial LP | $185 | 10 | 0,00% | Actions |
| Parallel Advisors, LLC | $92 | 5 | 0,00% | Actions |
Initiés de la société 18 initiés · 5 dirigeants · 14 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert Ang | President and CEO | 6 novembre 2023 F | 680 925 | 0 | 0 | $0 |
| Nathan D. Jorgensen | Chief Financial Officer | 6 novembre 2023 F | 145 647 | 0 | 0 | $0 |
| Tirtha Chakraborty | Chief Scientific Officer | 6 novembre 2023 F | 133 952 | 0 | 0 | $0 |
| Eyal C. Attar | Chief Medical Officer | 6 novembre 2023 F | 51 533 | 0 | 0 | $0 |
| Christopher Slapak | Chief Medical Officer | 1 février 2022 A | — | 0 | 0 | $0 |
| David Zaccardelli | Administrateur | 7 juillet 2026 A | — | 0 | 0 | $0 |
| Wouter Joustra | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Andrew David Levin | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Michel Detheux | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Fouad Namouni | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Alexander Cumbo | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Daniella Beckman | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Erez Kalir | Administrateur | 11 juin 2026 A | — | 0 | 0 | $0 |
| Joshua Resnick | Administrateur | 26 mai 2023 A | — | 0 | 0 | $0 |
| Sven Ante Lundberg | Administrateur | 26 mai 2023 A | — | 0 | 0 | $0 |
| David Charles Lubner | Administrateur | 26 mai 2023 A | — | 0 | 0 | $0 |
| Matthew R Patterson | Administrateur | 26 mai 2023 A | — | 0 | 0 | $0 |
| Kush Parmar | Administrateur | 14 juin 2022 A | 1 766 634 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 4 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×19 dépôts | 21 juillet 2026 | 19,90% | Amendement | Campagne de conseil d'administration | SEC |
| ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Growth III Management B.V. | 23 décembre 2025 | 9,99% | Dépôt initial | Campagne de conseil d'administration | SEC |
| Reprogrammed Interchange LLC, Reid Hoffman ×9 dépôts | 17 octobre 2025 | 17,60% | Amendement | — | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar ×3 dépôts | 9 juillet 2025 | 3,50% | Amendement | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 19 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,15% | 54 358 NS | 30 avril 2026 | N-PORT |
| BIB · ProShares Trust | 0,03% | 1 536 NS | 31 mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 13 777 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 juillet 2026 | Quotidien |
| ITOT · iShares Trust | — | — | 5 août 2026 | Quotidien |
| IWV · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWN · iShares Trust | — | — | 17 août 2026 | Quotidien |
| IWO · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWM · iShares Trust | — | — | 18 août 2026 | Quotidien |
| IWC · iShares Trust | — | — | 18 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 juillet 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 juillet 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | — | — | 20 juillet 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 17 août 2026 | Quotidien |